Roche's commitment to public health
At Roche, we foster the achievement of Public Health goals for healthy communities through innovation, partnership and impact to health policy. Our focus is ensuring the highest patient impact and broadest geographic reach so the hardest-hit communities and underserved patient populations can receive access to testing. Driven by our commitment to fighting infectious diseases, we provide healthcare solutions rapidly and reliably in the U.S. and worldwide when and where they are needed most.
Sample extraction and sequencing
Solutions for RNA extraction, sequencing and research
RT-PCR tests
High-throughput, moderate complexity testing on the cobas x800 platform for COVID-19 and infectious diseases
cobas® SARS-CoV-2 Test
cobas® HIV-1/HIV-2 Qualitative Test
cobas® HIV-1 Test
cobas® HCV Test
cobas® HPV test with self collect
cobas® 5800, cobas® 6800 & cobas® 8800 Systems
Immunochemistry tests
COVID-19 serology, HIV, Hepatitis, Syphilis, and ToRCH testing all on one immunoassay platform
Elecsys® Anti-SARS-CoV-2 Test (EUA*)
Elecsys® Anti-SARS-CoV-2 S Test (EUA*)
*This product has not been FDA cleared or approved. For diagnostic use under Emergency Use Authorization only.
Near Patient Care and Population Health
Decentralized testing and results management platforms
cobas® 4-plex SARS-CoV-2, flu A/B, RSV